QuadMedicine, Inc. (KOSDAQ:464490)

Market Cap	190.26B
Revenue (ttm)	13.11B +195.5%
Net Income	-5.49B
EPS	-592.68
Shares Out	11.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	314,339
Average Volume	836,071
Open	15,500
Previous Close	15,690
Day's Range	14,900 - 16,450
52-Week Range	12,460 - 27,150
Beta	n/a
RSI	50.17
Earnings Date	n/a

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 464490